发明名称 USE OF PROLACTIN RECEPTOR ANTAGONIST AND CHEMOTHERAPEUTIC DRUG FOR TREATING OVARIAN CANCER
摘要 The present invention relates generally to the field of cancer diagnosis and treatment, and more particularly to compositions and methods that may be useful for eliminating cancer cells with stem-like characteristics. The disclosed compositions and methods may also be useful for managing breast cancer, ovarian cancer, cervical cancer or endometrial (uterine) cancer with metastases; and visualizing the cancer cells in patient's body. The compositions of the instant invention include human prolactin receptor antagonist G129R.
申请公布号 EP2640412(A1) 申请公布日期 2013.09.25
申请号 EP20110796851 申请日期 2011.11.16
申请人 ONCOLIX, INC. 发明人 CHEN, WEN, Y.
分类号 A61K38/22;A61K31/337;A61K45/06;A61P35/00;A61P35/04 主分类号 A61K38/22
代理机构 代理人
主权项
地址